Research & Life Sciences
Your CMS GUIDE Partner for Specialized Dementia Support
From Bedside to Bench and Back to Patients
We believe the tools to develop cures for neurodegenerative diseases are on the horizon. Our care model removes barriers to advancing these cures—from diagnosis to clinical trials and research.
Scaled disease populations for robust research
Specialist-led care models for precision insights
Focus on fast access and comprehensive diagnostics
Engaged patient populations actively participating in care
How We Partner With Research and Life Science Companies
We remove barriers to advancing cures by scaling disease populations, leveraging specialist-led care models, and providing fast diagnostics and engaged patient populations.
Discovery
Accelerate New Assets into Clinic
In-Vitro Modeling
Patient-derived 3D brain models that faithfully recapitulate disease features, allowing our lab to screen promising therapeutics
Proprietary cell models viable for new target discovery, target validation, and translational data generation
Clinical Development
Get Disease-Altering Treatments to Patients Faster
Expanded Access Programs
50-state, rapidly enrolled Expanded Access programs
Highly accessible patient engagement systems
FDA-grade data collection and management
Clinical Trial Site / Hybrid Support
Fully functional decentralized trial site operations
Comprehensive support for recruitment, study assessments, in-home sample collection and more
Post-Approval / Commercial
Understand What Works for Patients, When, and Why
Patient Access
- Access point for patients to engage with disease specialists and understand treatment options
Patient Journey Analytics
Detailed insights and analytics to understand access, barriers and patient needs
Track real-world care patterns across geographies and payers
Identify friction points in diagnosis, referral, and treatment initiation
RWE: Prospective Studies
Deeply phenotyped and diverse patient population
Rapid enrollment through engaged clinicians across all 50 states
Standardized clinical assessments and biosample collection at scale
RWE: Retrospective Studies
High-fidelity retrospective population analysis; outcomes data for publication
Longitudinal EMR data spanning early symptoms to long-term outcomes
Rich data across demographics, comorbidities, and treatment patterns
Partner with Synapticure to Transform Patient Outcomes
If you’re interested in discussing opportunities with our team or would like to connect at upcoming events, please contact us.